Repligen Corp
(NAS:RGEN)
$
125.62
-0.32 (-0.25%)
Market Cap: 7.02 Bil
Enterprise Value: 6.99 Bil
PE Ratio: 502.48
PB Ratio: 3.56
GF Score: 96/100 - Q1 2024 Repligen Corp Earnings Call TranscriptMay 01, 2024$158.36 (-3.56%)Earnings
- Q4 2023 Repligen Corp Earnings Call TranscriptFeb 21, 2024$194.1 (-2.82%)Earnings
- Repligen Corp at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Repligen Corp at Stephens Investment Conference TranscriptNov 16, 2023
- Repligen Corp at Stifel Healthcare Conference TranscriptNov 15, 2023
- Q3 2023 Repligen Corp Earnings Call TranscriptOct 31, 2023$134.56 (+17.86%)Earnings
- Repligen Corp at Wells Fargo Healthcare Conference TranscriptSep 08, 2023
- Q2 2023 Repligen Corp Earnings Call TranscriptAug 02, 2023$170.48 (+2.01%)Earnings
- Repligen Corp at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Repligen Corp at William Blair Growth Stock Conference TranscriptJun 08, 2023
- Q1 2023 Repligen Corp Earnings Call TranscriptMay 02, 2023$157.23 (+2.40%)Earnings
- Repligen Corp at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (Virtual) TranscriptMar 21, 2023
- Q4 2022 Repligen Corp Earnings Call TranscriptFeb 22, 2023$169.98 (-4.51%)Earnings
- Repligen Corp at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Repligen Corp at Stephens Investment Conference TranscriptNov 17, 2022
- Repligen Corp at Stifel Healthcare Conference TranscriptNov 16, 2022
- Q3 2022 Repligen Corp Earnings Call TranscriptNov 01, 2022$185.55 (+1.68%)Earnings
- Repligen Corp Investor Day TranscriptSep 20, 2022
- Q2 2022 Repligen Corp Earnings Call TranscriptAug 02, 2022$237.38 (+11.68%)Earnings
- Repligen Corp at Jefferies Healthcare Conference TranscriptJun 09, 2022
- Repligen Corp at William Blair Growth Stock Conference TranscriptJun 07, 2022
- Q1 2022 Repligen Corp Earnings Call TranscriptApr 27, 2022$157.51 (+10.49%)Earnings
- Repligen Corp at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) TranscriptMar 22, 2022
- Repligen Corp at SVB Leerink Global Healthcare (Virtual) TranscriptFeb 18, 2022
- Q4 2021 Repligen Corp Earnings Call TranscriptFeb 17, 2022$182.42 (-0.87%)Earnings
- Repligen Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Repligen Corp at Stifel Healthcare Conference (Virtual) TranscriptNov 17, 2021
- Q3 2021 Repligen Corp Earnings Call TranscriptOct 28, 2021$290.02 (+7.00%)Earnings
- Q2 2021 Repligen Corp Earnings Call TranscriptJul 27, 2021$226.38 (+9.89%)Earnings
- Repligen Corp at Jefferies Healthcare Conference (Virtual) TranscriptJun 03, 2021
- Repligen Corp at William Blair Growth Stock Conference (Virtual) TranscriptJun 01, 2021
- Q1 2021 Repligen Corp Earnings Call TranscriptMay 04, 2021$194.67 (-6.46%)Earnings
- Repligen Corp at KeyBanc Capital Markets Life Sciences & Medtech Investor Forum (virtual) TranscriptMar 24, 2021
- Repligen Corp at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Repligen Corp at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 26, 2021
- Q4 2020 Repligen Corp Earnings Call TranscriptFeb 24, 2021$215.58 (+4.39%)Earnings
- Repligen Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Repligen Corp at Stephens NASH Investment Conference (Virtual) TranscriptNov 19, 2020
- Repligen Corp at Stifel Virtual Healthcare Conference TranscriptNov 18, 2020
- Q3 2020 Repligen Corp Earnings Call TranscriptNov 05, 2020$201.86 (+8.02%)Earnings
- Q2 2020 Repligen Corp Earnings Call TranscriptJul 30, 2020$151.25 (+8.99%)Earnings
- Repligen Corp at William Blair Growth Stock Conference TranscriptJun 11, 2020
- Repligen Corp at Jefferies Healthcare Conference (Virtual) TranscriptJun 03, 2020
- Repligen Corp at UBS Global Healthcare Conference (Virtual) TranscriptMay 18, 2020
- Repligen Corp Annual Shareholders Meeting TranscriptMay 13, 2020
- Q1 2020 Repligen Corp Earnings Call TranscriptMay 06, 2020$124.71 (+8.90%)Earnings
- Repligen Corp at Barclays Global Healthcare Conference TranscriptMar 11, 2020
- Q4 2019 Repligen Corp Earnings Call TranscriptFeb 20, 2020$101.12 (-7.35%)Earnings
- Repligen Corp at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Q3 2019 Repligen Corp Earnings Call TranscriptOct 31, 2019$79.49 (+3.05%)Earnings
- Q2 2019 Repligen Corp Earnings Call TranscriptAug 01, 2019$95.51 (+1.19%)Earnings
- Repligen Corp at UBS Global Healthcare Conference TranscriptMay 21, 2019
- Q1 2019 Repligen Corp Earnings Call TranscriptMay 09, 2019$69.86 (+3.39%)Earnings
- Repligen Corp to Acquire C Technologies Inc - M&A Call TranscriptApr 26, 2019
- Q4 2018 Repligen Corp Earnings Call TranscriptFeb 21, 2019$58.05 (-1.61%)Earnings
Repligen Corp at William Blair Growth Stock Conference (Virtual) Transcript
Jun 01, 2021 / 05:40PM GMT
Release Date Price:
$172.75
(-5.40%)
John Charles Kreger
William Blair & Company L.L.C., Research Division - Partner & Co-Group Head of Healthcare Technology and Services
All right. Good afternoon, everyone. Welcome to our next session at the William Blair Growth Stock Conference that is Repligen. Thank you all for joining us. I'm John Kreger, the analyst that covers Repligen at William Blair. You can see our website at williamblair.com for any conflicts of interest or other disclosures. As we've been doing all morning, this is going to be a fireside chat. The speaker is Tony Hunt, the CEO. So we've got 30 minutes with Tony. Tony, thank you again for your time.
Anthony J. Hunt
Repligen Corporation - CEO, President & Director
Yes. Thank you, John.
John Charles Kreger
William Blair & Company L.L.C., Research Division - Partner & Co-Group Head of Healthcare Technology and Services
Wonderful. And again, for those of you listening, I'll be delivering the questions to Tony. But if any of you have questions, feel free to submit them to
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)